Biomed-Lublin Wytw.Sur.i Szcz. Inhaber-Aktien ZY -,10

Sector and Industry

Healthcare, Biopharmaceuticals

Performance (1Y)

45.31%

Market Cap

-

P/E Ratio

0.00

Dividend Yield

0.00 %

Earnings per Share

-0.06 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
Eli Lilly and Company864.54 Bil.57.78 Bil.46.82
+86.88 %
0.00
-
Johnson & Johnson425.70 Bil.83.48 Bil.18.82
+82.71 %
0.00
-
AbbVie Inc.343.94 Bil.54.21 Bil.96.78
-5.29 %
0.00
-
Roche Holding AG286.62 Bil.65.80 Bil.20.72
+58.45 %
0.00
-
AstraZeneca PLC244.91 Bil.52.09 Bil.27.55
+39.41 %
0.00
-
NOVARTIS AG 224.76 Bil.48.44 Bil.18.30
+12.45 %
0.00
-
Merck & Co. Inc.221.79 Bil.57.55 Bil.14.46
+2.25 %
0.00
-
Novo-Nordisk AS B193.52 Bil.41.49 Bil.14.11
+1.54 %
0.00
-
Amgen Inc.150.16 Bil.32.57 Bil.23.01
+80.77 %
0.00
-
Gilead Sciences Inc.129.70 Bil.26.10 Bil.18.10
+1,599.93 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE0.631 G0 Units
PRICE DETERMINATION TIME07/21/2026 / 09:32:58 AM
DAILY VOLUME (UNITS)0
DAILY HIGH / LOW0.6330.631
PREV. DAY'S PRICE0.63 (07/20)
CHANGE DAY BEFORE
+0.00
0.16 %
52 WEEK HIGH / LOW1.148 (07/18)0.597 (06/05)
More Price Information

Key Figures (in EUR)

2023202420252026e2027e
EARNINGS PER SHARE
0.010.02-0.06-0.05-0.02
DIVIDENDS PER SHARE
0.000.000.000.000.00
DIVIDEND YIELD IN %
0.00 %0.00 %0.00 %--
DIVIDEND GROWTH IN %
-----
PRICE - EARNINGS RATIO
63.0742.24---
PRICE - BOOK RATIO
2.662.632.22--
PRICE - SALES RATIO
5.124.446.30--
PRICE - CASH FLOW RATIO
-23.2336.65--
Further Key Figures

Master Data

WKN
A1J10U
ISIN
PLBMDLB00018
SYMBOL
6NQ
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
BIOMED-LUBLIN WYT.SUR.
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
-
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Biopharmaceuticals
NUMBER OF SHARES
-
MARKET CAPITALISATION
-

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
-1.10 %
-1.10 %
-28.08 %
-32.19 %
-45.31 %
-49.36 %
-68.18 %
-21.05 %
HIGH0.640.730.870.961.151.292.201.00
LOW0.610.610.600.600.600.600.540.60

Dividende

pro Aktie
BIOMED-LUBLIN WYT.SUR. does not deliver dividend information

Company profile

Synthaverse SA engages in the manufacture of pharmaceutical products. It offers prescription and over-the-counter medicines, medical devices, and laboratory reagents. The company was founded on December 4, 1944 and is headquartered in Lublin, Poland.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.